Statin use vs. average non-HDL cholesterol levels in Guatemala

Guatemala: Statin use vs. average non-HDL cholesterol levels was 3.5 in 2018. ▲ Rising

Latest (2018)
3.5
Change on year
unchanged
World rank
52nd
of 191 countries
All-time high
3.5
in 2001
All-time low
3.3
in 1980
Years of data
39
1980–2018

Statin use vs. average non-HDL cholesterol levels in Guatemala, 1980–2018

012341980199920181980: 3.31981: 3.31982: 3.31983: 3.31984: 3.31985: 3.31986: 3.31987: 3.31988: 3.41989: 3.41990: 3.41991: 3.41992: 3.41993: 3.41994: 3.41995: 3.41996: 3.41997: 3.41998: 3.41999: 3.42000: 3.42001: 3.52002: 3.52003: 3.52004: 3.52005: 3.52006: 3.52007: 3.52008: 3.52009: 3.52010: 3.52011: 3.52012: 3.52013: 3.52014: 3.52015: 3.52016: 3.52017: 3.52018: 3.5

Source: World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.

Analysis

The most recent figure for statin use vs. average non-hdl cholesterol levels in Guatemala is 3.5, measured in 2018. That is the highest value across all 39 years on record.

The figure is unchanged over ten years.

Over the whole period, statin use vs. average non-hdl cholesterol levels in Guatemala peaked at 3.5 in 2001 and was at its lowest, 3.3, in 1980.

Guatemala ranks 52nd of 191 countries on this measure, in the middle of the range.

The long-run direction has been consistently rising across the 39 years of available data.

Averages by decade

DecadeAverage LowestHighest Years
1980s 3.32 3.3 3.4 10
1990s 3.4 3.4 3.4 10
2000s 3.49 3.4 3.5 10
2010s 3.5 3.5 3.5 9

Countries ranked near Guatemala

  1. 52 Antigua and Barbuda 3.5 compare
  2. 52 Bahamas 3.5 compare
  3. 52 Cyprus 3.5 compare
  4. 52 Czechia 3.5 compare
  5. 52 Dominica 3.5 compare
  6. 52 El Salvador 3.5 compare
  7. 52 Finland 3.5 compare
  8. 52 Greece 3.5 compare
  9. 52 Grenada 3.5 compare
  10. 52 Haiti 3.5 compare
  11. 52 Iraq 3.5 compare
  12. 52 Italy 3.5 compare
  13. 52 Maldives 3.5 compare
  14. 52 Micronesia (country) 3.5 compare
  15. 52 Norway 3.5 compare
  16. 52 Paraguay 3.5 compare
  17. 52 Poland 3.5 compare
  18. 52 Saint Kitts and Nevis 3.5 compare
  19. 52 Saint Lucia 3.5 compare
  20. 52 Trinidad and Tobago 3.5 compare
  21. 52 United Arab Emirates 3.5 compare
  22. 52 Vietnam 3.5 compare

See the full ranking of 191 places →

More reference data data for Guatemala

All data for Guatemala →

Frequently asked questions

What is statin use vs. average non-hdl cholesterol levels in Guatemala?
Statin use vs. average non-hdl cholesterol levels in Guatemala was 3.5 in 2018, according to World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.
What is the highest statin use vs. average non-hdl cholesterol levels recorded in Guatemala?
The highest recorded value was 3.5 in 2001.
What is the lowest statin use vs. average non-hdl cholesterol levels recorded in Guatemala?
The lowest recorded value was 3.3 in 1980.
How does Guatemala rank for statin use vs. average non-hdl cholesterol levels?
Guatemala ranks 52nd out of 191 countries with data for 2018.
Is statin use vs. average non-hdl cholesterol levels rising or falling in Guatemala?
Over the last ten years it is unchanged. The long-run trend across the full record is rising.
Where does this Guatemala data come from?
The figures come from World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as part of Statin use vs. average non-HDL cholesterol levels. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 39 observations, free to reuse under CC BY 4.0 (Our World in Data).

About this data

Indicator
Statin use vs. average non-HDL cholesterol levels
Source
World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
191 places, 7,449 data points, 1980–2018
Last refreshed

The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.